Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Honorary Clinical Senior Lecturer







ICTEM buildingHammersmith Campus





Taryn Youngstein is a consultant Rheumatologist at the Hammersmith Hospital, Imperial College Healthcare NHS Trust and an honorary clinical senior lecturer at Imperial College London.

She has a specific interest in inflammation and its targeted treatment. Following award of her MD in Amyloidosis and Acute Phase Protein research from the National Amyloidosis Centre, University College London, Taryn was appointed Consultant in Rheumatology at ICHT. She has a clinical and research interest in hyperinflammation syndromes, periodic fever and vasculitis. Taryn is a co-director of the new Imperial College Centre of Excellence in Vasculitis Research and is the Trust-wide Lead for Supported Return to Training, a crucial role in supporting those returning to clinical practice from periods of research, in industry or prolonged periods of leave.

Taryn is a member of the British Society for Rheumatology for which she sits on the COVID-19 CRG and was part of the team creating the national shielding guidance for the immunosuppressed in conjunction with Public Health England. Taryn is also a member of the International Society of Systemic Auto-inflammatory Diseases.



The ATTACC, ACTIV-4a, and REMAP-CAP Investigators, 2021, Therapeutic anticoagulation with heparin in noncritically Ill patients with Covid-19, New England Journal of Medicine, Vol:385, ISSN:0028-4793, Pages:790-802

The REMAP-CAP, ACTIV-4a, and ATTACC Investigators, 2021, Therapeutic anticoagulation with heparin in critically Ill patients with Covid-19, New England Journal of Medicine, Vol:385, ISSN:0028-4793, Pages:777-789

Arabi Y, Gordon A, Derde L, et al., 2021, Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized control trial, Intensive Care Medicine, Vol:47, ISSN:0342-4642, Pages:867-886

Domingo P, Mur I, Mateo GM, et al., 2021, Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19, Jama, ISSN:0098-7484

Porter A, Youngstein T, Babar S, et al., 2021, A rare life-threatening presentation of Takayasu arteritis, Rheumatology, Vol:60, ISSN:1462-0324, Pages:6-8

More Publications